AAOS carpal tunnel guidance favors clinical diagnosis in typical cases

A synopsis of the 2024 AAOS carpal tunnel syndrome guideline highlights recommendations for nonoperative clinicians. It supports clinical assessment with the CTS-6 for typical presentations, reserving imaging or electrodiagnostic testing for selected cases, and notes that several commonly used treatments lack evidence of benefit.

Use CTS-6 to assess typical presentations.
Reserve diagnostic tests for selected cases.
Steroid injections offer short-term, not sustained, benefit.
Several commonly used treatments lack evidence of benefit.

Carpal tunnel syndrome (CTS) is commonly encountered in primary care and internal medicine. This article summarizes the 2024 American Academy of Orthopaedic Surgeons (AAOS) clinical practice guideline, developed by a multidisciplinary panel after a systematic literature review. Recommendations were graded according to evidence strength and consensus; the synopsis focuses on diagnosis, treatment and referral decisions for nonoperative clinicians.

For typical symptoms and examination findings, the guideline supports using the validated Carpal Tunnel Syndrome-6 (CTS-6) as the primary diagnostic approach. Routine ultrasonography or electrodiagnostic testing is not required in these cases; such tests may help when the diagnosis is uncertain or in potentially recurrent cases. MRI and upper-limb neurodynamic testing are not recommended for routine diagnosis. Corticosteroid injections may provide short-term symptom relief but do not change the long-term course. The guideline does not recommend therapeutic ultrasound, oral corticosteroids, nonsteroidal anti-inflammatory drugs or platelet-rich plasma injections because evidence of clinical benefit is lacking.

For moderate-to-severe symptoms, thenar atrophy or failure of nonoperative management, carpal tunnel release may be considered, by either open or endoscopic technique. Routine preoperative testing is not recommended for otherwise healthy patients. This is a guideline synopsis, not a new clinical trial; the authors note that some recommendations rely on limited evidence or consensus. The article also describes evidence supporting night splinting, although splinting was not specifically evaluated in the AAOS guideline.

In practice

For patients with typical carpal tunnel symptoms and examination findings, clinicians can use the CTS-6 as the primary diagnostic approach rather than routinely ordering ultrasonography or electrodiagnostic studies. Testing may be useful when the diagnosis is uncertain or in potentially recurrent cases. Corticosteroid injection may relieve symptoms in the short term but does not alter the long-term disease course; several other commonly used interventions are not recommended for lack of demonstrated benefit. This is a synopsis of the 2024 AAOS guideline, and some recommendations reflect limited evidence or consensus.

AI-generated clinical interpretation · Not editor-reviewed

AI summary · Not yet editor-reviewed

Is this summary clinically accurate?

Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.

Source

Journal of General Internal Medicine: AAOS Clinical Practice Guidelines for Carpal Tunnel Syndrome: Synopsis and Practice Implications ↗

This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.